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ABSTRACT
Stargardt disease-4 (STGD4) is an autosomal dominant complex, genetically 
heterogeneous macular degeneration/dystrophy (MD) disorder. In this paper, we 
used targeted next generation sequencing and multiple molecular dynamics analyses 
to identify and characterize a disease-causing genetic variant in four generations 
of a Chinese family with STGD4-like MD. We found a novel heterozygous missense 
mutation, c.734T>C (p.L245P) in the PROM1 gene. Structurally, this mutation most 
likely impairs PROM1 protein stability, flexibility, and amino acid interaction network 
after changing the amino acid residue Leucine into Proline in the basic helix-loop-
helix leucine zipper domain. Molecular dynamic simulation and principal component 
analysis provide compelling evidence that this PROM1 mutation contributes to disease 
causativeness or susceptibility variants in patients with STGD4-like MD. Thus, this 
finding defines new approaches in genetic characterization, accurate diagnosis, and 
prevention of STGD4-like MD.
INTRODUCTION
Stargardt disease (STGD) is a common, 
heterogeneous juvenile-onset macular degeneration/
dystrophy (MD) disease with an estimated incidence of 
10-12.5 per 100,000 people [1, 2]. Clinically, STGD is 
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usually characterized by decreased central vision, night 
blindness, mildl atrophy of the macular photoreceptor 
cells, underlying retinal pigment epithelium, and gradual 
appearance of fundus flecks in the posterior pole of the 
retina [3]. This STGD disease is mostly inherited as an 
autosomal recessive trait of STGD (arSTGD) while 
Stargardt disease-4 (STGD4) is an autosomal dominant 
trait (adSTGD), which is associated with mutations in 
various genes. STGDs are mutagenetically categorized 
in three types/genes: ABCA4 gene mutation (1p22.1) 
(STGD1 [MIM248200]) [4-6], ELOVL4 gene mutation 
(6q14.1) (STGD3 [MIM600110]) [2, 7, 8], and PROM1 
gene mutation (4p15.32) (STGD4 [MIM603786]) [9-11]. 
Most recent families of MD and adSTGD-like genes were 
mapped and described in the STGD4 locus of patients with 
retinitis pigmentosa (RP) [10, 12].
PROM1 (Gene ID: 8842, also named as PROML1, 
CD133 and AC133) encodes prominin (mouse)-like 
1 protein Prominin-1 containing 97 kDa protein with 
865-amino acid. As a topic glycoprotein, PROM1 
constitutes a 5-transmembrane domain glycoprotein with 
two short N (extracellular)- and C (cytoplasmic)-terminal 
tails and two large N-glycosylated extracellular loops in 
both rod and cone photoreceptor cells. Prominin-1 has 
been expressed originally in ependymal cells, human 
fetal spinal cords, and the oligodendroglia [13, 14] and is 
a well characterized biomarker of normal and cancerous 
stem cells in the central nervous system [15]. PROM1 is 
positioned at the apical surface of retinoblastoma cell lines 
and adult retina [16, 17]. Current scientific literatures have 
indicated that the PROM1 is likely to be involved in the 
protrusion, organization, and cholesterol composition of 
the plasma membrane [18]. In addition, PROM1 plays 
crucial roles in the biogenesis of photoreceptor rod discs 
concentrated in plasma membrane evaginations of the 
nascent disc membranes. Mutations in the PROM1 gene 
have also been reported in other MD diseases, such as 
STGD4 [10, 12, 19] and cone-rod dystrophy [9-11], which 
demonstrates that mutations in same gene may manifest 
multiple clinical phenotypes.
In STGD4-like MD, defective PROM1 is similarly 
involved in plasma membrane invaginations and disk 
malfunction, particularly in the myoid region of the 
photoreceptor [10, 20]. In the photoreceptor cells of 
STGD4-like MD, PROM1 cannot be migrated into 
the outer segment where disks are formed, leading to 
disk malfunction and vision problem [21]. Even with 
developing knowledge, the function and mediator roles 
of PROM1 in MD disease are not well characterized.‎ 
Despite numerous genetic studies focused on identifying 
of PROM1 mutation (mainly frameshift) in Pakistani 
[20], Saudi Arabian [22], Spanish [9], and Indian [18] 
families with MD degeneration, the molecular roles of 
these mutations are still obscure. An interesting area to 
continue research is the specific mechanism of mutations 
on the PROM1 gene in the disk morphogenesis, as well as 
how this misallocation of disks in photoreceptors could be 
transmitted as an autosomal dominant trait and/or as an 
autosomal recessive trait.
In this study, we considered a Chinese family with 
STGD4-like MD that has a novel, deleterious, pathogenic 
and disease-causing mutation, c.734T > C (p.L245P), in 
the PROM1 gene. The structural, molecular dynamics 
and energetic analysis of the wild and mutational types 
of PROM1 gave us a clear overview of the fundamental 
process at the molecular level. A combination of 
molecular dynamic simulations and principal component 
analysis (PCA) is applied to investigate the molecular 
mechanism of the mutation’s conformational diversity. 
Free energy landscapes (FEL) based on trajectories of 
the simulation also provide detailed information related 
to be conformational changes of proteins. Thus, FEL 
using multiple physical parameters from the molecular 
simulation trajectory are calculated to reveal related 
energetic information of the mutation’s conformational 
diversity.
RESULTS
Pedigree information and clinical findings
A four-generation pedigree (M107, proband: II: 2) 
of a Chinese family, in which one or more members have 
a mixed retinal dystrophy, was created in the study (Figure 
1A). The proband, 63 years old women, claimed to have 
issues with sight ever since the age of 42 with bilateral 
Bull’s eye maculopathy. The images of the proband 
are documented by fundus photography (FP), fundus 
autofluorescence (FA), electroretinograms (ERGs), and 
optical coherence tomography (OCT), which are shown in 
Figure 1B-1G, respectively. As the FA results illustrated, 
the absence of a normal darkened presence, replacement 
of a central reddish orange hue and close mottling 
(especially in the left eye, Figure 1B-1C), bilateral macular 
discoloration, and peripheral mottling with intraretinal 
pigment clumping (especially in the right eye, Figure 1D-
1E) are major abnormalities in the retinal examination. 
The FA showed dark choroid with limited staining of some 
white fundus flecks in both eyes. Our results revealed 
possible chorioretinal atrophy in the right eye, which is 
highlighted by perifoveal and parafoveal hypofluorescent 
(Figure 1E). The outer retinal architecture in left and right 
eyes was lost, respectively (Figure 1F-1G), which was 
extremely apparent in the macula. Importantly, macular 
progressive depigmentation with pigment clumping and 
atrophy is a major complement of the proband. 
Other patients showed similar clinical and 
ophthalmological abnormalities. Tunnel vision and loss 
of peripheral vision were apparent in all patients. The 
presenting symptoms for proband and pedigree II:6 were 
Oncotarget124www.impactjournals.com/oncotarget
Figure 1: Pedigree of the M107 family with autosomal dominant Stargardt4-like macular dystrophy and clinical 
assessment of affected proband. A. Pedigree of the M107 family. Family number and disease-causing mutation (s) are noted at this 
pedigree. Normal individuals are shown as clear circles (females) and squares (males), affected individuals are shown as filled symbols. 
The patient above the arrow indicates proband (II: 2) (molecular no.: M107). Individuals with heterozygous mutation are represented in 
filled symbols. Targeted next generation sequencing individual indicated with arrow. B., D. Fundus photography of the left and right eyes, 
respectively. C., E. Fundus autofluorescences of left and right eyes, respectively. F., G. OCT characterization ‎of the left and right eyes 
with conclusive genetic defects, respectively. The macular progressive depigmentation with atrophy and pigment clumping are major 
complement of proband.
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more severe, especially in night blindness. Based on our 
pedigree analysis in the proband, there were decreased 
central vision and visual acuity, and a prominent presence 
of fundus flecks in the posterior pole of the retina, which 
demonstrated a late onset STGD4-like MD. Neither 
STGD4-like MD nor MD-related ophthalmological 
defects was observed in other recruited normal family 
members. 
Mutation identification and segregation analysis
Targeted exome sequencing (TES) was analyzed 
using a genomic DNA (gDNA) sample of the proband 
(pedigree II:2) from the STGD4-like MD affected Chinese 
family. In total, more than 10 million bases of the sequence 
with a 100-bp read length were generated, and 99% of 
the bases passed the quality assessment. However, 40,000 
single nucleotide polymorphisms (SNPs) and Insertions/
Deletions (INDELs) were found. Then, 99% of the billion 
bases were aligned with the human reference sequence, 
which had billions of bases covered by a 40-fold coverage 
target region. As the data was filtered, we excluded known 
variants recorded in dbSNP137, 1000 genomes project, 
and HapMap with minor allele frequency (MAF) > 0.50%. 
Next, the missense mutations in the PROM1 gene were 
selected for segregation analysis and conformational 
Sanger sequencing (Figure 2). We identified a novel 
heterozygous missense mutation (c.734T > C) of PROM1 
gene (NM_006017) (depicted in Figure 1A with pedigree 
II:2 and IV:2, respectively; Figure 2A-2B), leading to a 
change of amino acid from Leu to Pro at the 245th position 
of PROM1 protein (p.L245P). The c.734T > C variant was 
consequently validated based on its absence in unaffected 
family individuals and unrelated normal controls (100 
individuals), which consisted of normal people without a 
family history of eye disease (wild type, depicted in Figure 
1A with pedigree IV:1; Figure 2C). This variant was 
confirmed by Sanger sequencing and it showed complete 
segregation in this pedigree M107 family association 
furthering population studies and pinpointing its role in 
STGD4-like MD pathogenesis. 
The predictions of conservation and damage 
in the c.734T > C (p.L245P) ‎mutation on the 
PROM1 ‎protein
The PROM1 protein alignment analysis based on 
multiple sequence alignment in different organisms’ genes 
is shown in the Supplementary Figure S1. The nucleotide 
change results in a Pro substitution for a highly conserved 
Leu at residue 245 (p.L245P). The PROM1 p.L245P 
mutation in a basic helix-loop-helix leucine zipper domain 
(bHLH-Zip) indicates an important role in transcriptional 
regulation of PROM1 in patients with STGD4-like MD, 
thereby contributing to disease progress. Computer-
based protein analysis in different species indicates that 
this variant is likely a pathogenic mutation (Table 1). 
The damaging consequence on protein indicates that the 
variant in PROM1 gene was probably “disease-causing” 
with a score of 1 on Polyphen-2 and 0.01 score in scale-
invariant feature transform (SIFT) prediction analysis 
(sensitivity: 0.01; specificity: 1.00). Also, Mutation Taster 
predicted that the PROM1 heterozygous mutations c. 
734T > C (P.L245P) is functionally ‘‘damage-causing’’ 
(Mutation Taster score is 98). I-Mutant3.0 (stability 
predictors, DDG < 0 (decrease stability) and DDG > 0 
(increase stability)) showed the variant decreased stability 
with a score of -1.59 kcal/mol (Table 1). 
Quality check of constructed model
Our homology modeling results were evaluated to 
choose the best constructed model for other processes. 
The overall quality of the model was further checked 
using ProSA-web server, then the Z-score of the models 
were calculated. The 3D model was accepted based on 
the standards of the ProSA-web server. The ProSA-web 
Z-score is an indicator of the overall quality of a model. In 
this regard, ProSA-web Z-score of the studied model was 
negative and within the range of -4 to -4.30, indicating it 
has desirable qualities (Supplementary Table 1). Further 
confirmation of the 3D models was performed using 
quantitative model energy analysis (QMEAN) tools, 
supporting the quality for the model (Supplementary Table 
1). Scoring function was assessed based on geometrical 
analysis using QMEAN Z-score for all modeled structures. 
Table 1: Characteristics of PROM1 SNP in Chinese family with adSTGD and analysis of their predicted protein 
structure and disease-causing effects.
Exon
Variation
Polyphen-2 Mutation Taster I-Mutant3.0 SIFT EXACNucleotide* Protein* Type Status
7 c.734 T>C P.L245P Missense Heter PD (1.000) DC (98) DS (-1.59 kcal/mol) D (0.01) Novel
Abbreviations: c, variation at cDNA level; p, variation at protein level; L245P, Proline substitution conserved leucine at codon 
245; Heter, heterozygote; PD, probably damaging; DC, disease causing; DS, Decrease stability; D, damaging.
‎* All nucleotide and amino acid abbreviated according the International Union of Pure and Applied Chemistry ‎‎(IUPAC). ‎
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Figure 2: Sequencing results of the (c.T734C:p.L245P) PROM1 mutation. A. The novel heterozygous missense mutation 
(PROM1: NM_006017: exon7: c.T734C:p.L245P) of PROM1 gene in proband (II:2). B. Sanger sequencing results of IV:2 identified as a 
wild type. C. The wild type IV:1 was validated in the unaffected family individuals and unrelated normal controls, with the normal male 
from no eye disease history family (III:1). All number were depicted in Figure 1. The arrows indicate the mutation at the nucleotide position 
c. 734T > C in the PROM1 gene. 
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This result shows the quality of constructed model based 
on the template including 0.3 to 0.4. 
Results of molecular dynamic simulation analysis
To evaluate the structural deviation of both wild and 
mutated residue during the simulation, distributions of root 
mean square deviation (RMSD) of backbone atoms were 
calculated. We investigated the structural and functional 
consequences of the reported deleterious point mutation as 
an active site domain of PROM1 during a 130 nanosecond 
(ns) molecular dynamic simulations phase (Figure 3). 
The RMSD values of the PROM1 backbone atoms in the 
entire molecular dynamic simulation trajectory (130 ns) 
are shown in Figure 3A. As seen in this figure, the wild 
type equilibrates after 25 ns with the structure maintaining 
Figure 3: Functional effects of the c.734T > C ‎mutation on the PROM1 ‎protein. A. RMSD plots of the wild-type and the 
L245P complex systems for 130 ns of simulation, where time step is plotted on X-axis while RMSD (nm) is plotted on Y-axis. B. Difference 
in average Cα-RMSF of the L245P mutant (red) and the wild type (blue). ‎The maxima differences of residue-level displacements and 
fluctuations of both systems are shown in the residues numbers 70-77 and 183-191. C. The secondary structure as a function of the 
simulation time for two model structures. Upper and lower panels indicate secondary structure for the wild-, and -mutant type in the two 
main functional extracellular domains of PROM1 protein, 70-77 (upper panel) and 183-191 (lower panel) amino-acid residues, respectively. 
This finding indicates the initial structure of PROM1 in the wild type showing as a turn structure while the L245P mutant converted to an 
alpha helix during the simulation time (residues number 70-77) (upper panel). Secondary structure analysis in the residues number 183-191 
shows this position including a turn conformation at the end of simulation in wild type, whereas the L245P mutant depictes an alpha-helix 
during 90 ns and all structures finally returned to the initial conformation at the end of simulation times. D. 3D structure from the wild 
type and the L245P mutant of PROM1 represent in gray and red color, respectively. Substitution of the Leu with Pro changes the α-helical 
structure of bHLH-Zip domain. The position of the p.L245P mutation is reported in blue color on the both structures. E. Far-UV CD spectra 
of secondary structure analysis of the wild and the mutant PROM1 during 130 ns-MD simulations. The two minima at 195 and 210 nm 
indicate an α-helical structure. 
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a level of 30 Å, whereas the mutant variant shows a 
significant decrease (P = 0.031) in the RMSD value with 
more fluctuations containing low stabilization, which has 
an average of ≈ 12 Å. During the simulation, the L245P 
mutant backbone atoms were aligned with RMSDs of less 
than 20 Å, however fluctuations were remarkably visible 
over the course of simulation.‎ 
We also calculated the residue-based root mean 
square fluctuation (RMSF) differences between each 
amino acid of PROM1 to directly gain insights into the 
structural fluctuation and flexibility of this point mutation; 
details are shown in Figure 3B. We found that the L245P 
point mutant protein has different fluctuation patterns than 
the wild-type protein. The RMSF graph clearly shows that 








number Outlier region (%)
Outlier a.a. 
number
Wild-Type 72.9 183 19.9 50 7.2 18
L245P Mutant 74.9 188 18.7 47 6.4 16
Abbreviations: a.a: amino acids; L245P, Proline substitution conserved leucine at codon 245.
Figure 4: Tertiary structural stability of the (c.734T > C) p.L245P‎ mutant PROM1. A. Structural superposition of the wild- 
(red) and the mutant-type (blue) domains extracted from the trajectories of 20, 80, and 100 ns. The mutation of L245P and the residue 
Leu245 of wild type are labeled in green color. The helices and hinge indicate with arrows. α1: residues number 70-77, α2: bHLH-Zip 
domain, and α3: residues number: 183-191. B. Plot of average RG values for each of the systems. RG for L245P mutant and wild type 
are colored as red and blue, respectively. The chart also shows differential RG values between residues of WT and mutant forms. There 
is a strong prospect that the L245P mutation influences the structure of the active site of ‎PROM1, possibly by creating a further fold and 
destabilizing the mentioned domain. C. Comparative diagram depicting Ramchandran plot analysis of PROM1 protein variants in the wild 
type (upper panel) and the L245P mutant (lower panel) during 130 ns molecular dynamic simulations. Ramachandran plots show the phi 
(φ)-psi (ψ) torsion angles for the related residue number 245 of PROM1 in this structure. Leu and Pro residues are shown as square (□) 
and are not restricted to the regions of plots. In the upper panel, before mutation, Leu245 located in the 310 helix region, whereas mutated 
residue (L245P) transferred to the alpha helix parts of plot in the lower panel during the simulation time. 
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mutant variant has significantly higher fluctuations in the 
side chain residues from number 70 to 77. To understand 
the nature of these structural alterations, secondary 
structure assignments for all protein entries were 
performed using a defined secondary structure of protein 
(DSSP) algorithm [23]. Results from DSSP analysis 
confirmed these regions (residues number 70-77) in the 
structure generated during the simulation; furthermore, 
it revealed that the loop in the initial human PROM1 
structure folded into a small helix after the molecular 
dynamic simulation (Figure 3C-3D). In contrast, the 
simulated wild complex C-alpha atoms have more 
fluctuations in the 183-1910 residues number compared 
to mutant type (Figure 3B). This result indicates that the 
initial structure of PROM1 in wild type exhibits turn 
structure while L245P mutant is converted to alpha helix 
during 90 ns, before all structures returned to the initial 
conformation at the end of simulation times. Therefore, 
both RMSF and RMSD results demonstrated the L245P 
mutation markedly influences the structure of the active 
site of ‎PROM1. Circular dichroism (CD) server was used 
for analyzing secondary structure of the wild-type and 
mutant PROM1 in the wavelength of far-UV i.e., 195-
260 nm (Figure 3E). This graph clearly shows that the 
secondary structure of L245P mutant system is a more 
dominant alpha helix than that in the wild type with two 
minima around 195 and 210 nm, contributing to the stable 
structure of bHLH-ZIP domain of L245P mutant system.
To further study the evolution of the tertiary 
structural stability in a molecular dynamic biological 
system, we measured the structural alterations of the 
proteins during the simulation. For more details, the 
tertiary structural superposition of the wild type (red) 
and mutant (blue) were extracted in 20, 80, and 100 ns 
of simulations. In the wild-type simulation, the helices 
α1 (residues number 70-77), α2 (bHLH-Zip domain) and 
α3 (residues number 183-191) maintained their structures 
along the entire trajectory, whereas L245P mutant 
structure (compared to wild type conformation) exhibited 
a higher degree of flexibility, especially at position α2 
and α3. It seems that this fluctuation is associated to the 
hinge region. In the mutant domain, it appears that helices 
α2 and α3 are partially folded so that they are displaced 
from its original position, thereby affecting the relaxation 
in the bHLH-Zip of the active domain‎ core (Figure 4A). 
To examine the size of protein structure, we plotted the 
radius of gyration plot for the C-alpha atoms of protein 
versus time, shown in Figure 4B, where it is defined as 
the mass-weight root-mean-square distance of collection 
of atoms from their common center of mass. This provides 
an insight into the overall dimension of the protein. The 
Rg of each compound remains stable after 30 ns molecular 
dynamic simulation. The average values of the wild type 
and L245 mutant group are 2.16 ± 0.31 Å and 2.62 ± 0.32 
Å, respectively. Considerable increases in the Rg values 
showed about 23% for the mutant, indicateing the stability 
of the mutant compared to the wild type, especially in 
the hinge region of bHLH-Zip. Thus, stable Rg values 
along the trajectories indicate that the overall packing 
of bHLH-Zip is maintained during simulations. These 
events lead to unstable moments of inertia in the mutant 
(Figure 4B). Another approach to analyze the protein 
dynamics is to examine the hydrogen bond formation 
between all residues, which is considered as a major 
force in controlling the stable conformation of protein 
structure. This result is shown as in Supplementary Figure 
2. The mutant exhibited slightly lower total hydrogen 
bond interactions during 130 ns compared to the wild 
type. These results confirmed the instability of the overall 
mutant structure. 
The Ramachandran plots of the wild and L245P 
mutant types are provided in Figure 4C and Table 2. They 
showed that 19.9% and 18.7% of residues of the wild and 
L245P mutant types were placed in the allowed regions, 
respectively. This difference between wild and mutant 
systems is not as drastic, indicating the slight stabilization 
of the optimized human PROM1 structure. The residues 
located in the favored zone were also increased from 
72.9 to 74.9 during the molecular dynamic simulation. As 
shown in Figure 4C, the residue of the wild type (L245) 
falls in 310 helix regions of the Ramchandran plot (upper 
panel), whereas, after Pro245 substitution, the new residue 
is transferred to the alpha helix parts of the plot (lower 
panel). This provides evidence to further confirm the 
results of DSSP and secondary structure prediction. 
Table 3: Prominent residue contributing towards motions of the wild and the L245P-mutant across different modes.
Mode No. Residue numbers with highest mobility
Wild-Type
1 71, 74, 167, 168
2 120
3 59, 166, 174
L245P Mutant
1 252, 170, 168, 165
2 67, 78, 82, 83, 65, 86, 93, 228, 243, 245, 250
3 65, 67, 78, 82, 86, 90, 228, 243, 245, 250
Abbreviations: L245P, Proline substitution conserved leucine at codon 245.
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Structural ‎effects on the p.L245P ‎mutation in 
residue interaction networks
The residue interaction networks (RINs) analysis 
of a protein backbone is a new strategy that identifies 
key residue interactions. The RINs assays can be used 
to explore the differences between different proteins, 
including the proteins of the wild type and mutants. In 
this work, we investigated the relationship between key 
residues of the wild type and that of the L245P mutant 
by generating RINs and using representative structures 
from 130 ns of molecular dynamics (Figure 5). Evident 
from the RINs plot, comparison between the predicted 
key residues of the wild type Leu and that of mutated 
Pro in the 245th position revealed that the mutant residue 
changed the interaction within the network. In the wild 
type, the residue Leu245 forms one hydrogen bond with 
residue Glu249 (Figure 5A), whereas the mutant form 
exhibits that the Pro245 has the two hydrogen bonds with 
Leu 248 and Glu249. Also found in the mutant form of 
PROM1, the α-helical structure in the bHLH-Zip domain 
was noticeably stabilized through close atom interactions 
of Pro245 with Ile241, His242, Asn69, Val73, and Leu248 
(Figure 5B). In contrast, there are no interactions of 
Leu245 with Ile241, His242, Asn69, Val73, and Leu248 
in the wild-type system. As a result, analysis of RINs 
shows that the mutant residue changed the interaction 
within the network in comparison to the wild type, which 
made a more stabilized bHLH-Zip mutant structure in the 
extracellular domain of PROM1. Even so, L245P mutation 
affects the interactive network and the overall structure 
of the protein, leading to instability of the total structure 
of PROM1 protein. Hydrogen bonds in the overall 
structure of the wild type are slightly increased compared 
to the mutant type. Nevertheless, the specific hydrogen 
bond interactions in the mutated region were enhanced 
relative to the wild residue (Supplementary Figure 2), 
demonstrating that bHLH-Zip domain of the mutant type 
is more stable compared to the wild type. 
The p.L245P mutation of PROM1 dynamical 
properties increases fluctuation, flexibility and 
atomic density distribution
To detect main dynamical topographies of the 
wild-type and the mutant domains as well as highlight 
major conformational changes between the structures, 
we mathematically investigated the atomic positional 
fluctuations covariance matrix of the C-alpha atoms 
using the PCA method (Figure 6). In this study, two 
principal motions were considered to evaluate the general 
fluctuations; the first principal motion ‎‎(PC1) corresponding 
to the scissoring motion between the interacting residues, 
and another ‎one (PC2) indicateing a twisting motion. 
Figure 5: Residue interaction networks. A. RINs of the active functional extracellular domain residues of PROM1 position in the 
wild type and B. the L245P mutant forms. Wild type reported on H-bond with Glu249 and no closely atomic interaction with the surrounding 
residues. L245P mutant form shows two H-bond interaction with Leu248, Glu249, and several closer atomic interactions generated through 
Pro245 with Ile241, His242, Asn69, Val73, and Leu248. The more interactions between the L245P mutant and neighboring residues could 
be destabilized at the bHLH-Zip domain in 130 ns. 
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Figure 6A shows a scatter plot constructed for the wild-
type and L245P mutant in both types’ eigenvectors, PC1 
and PC2. As shown in Figure 6, the most fluctuations 
between all atoms of wild and mutant types ‎are between 
-1.088 to 1.88 and -0.95 to 2.96 nm, respectively during 
the ‎simulation. It means that the L245P mutant generates 
more scissoring motion along the ‎PC1 axis relative to 
the wild type. ‎A significant difference between these two 
systems are evident from the characteristic structures 
plotted along two principal components directions. The 
motions of the loop in both systems were described. PCA 
revealed that the L245P mutant inhibits a relatively wider 
phase space and shows higher fluctuation in contrast to 
the wild type. This result is congruent with the presented 
Rg graph. The molecular changes were depicted in the 
atomic density distribution plot (Figure 6B-6C). There was 
a clearly, significant change in the density distribution of 
the native compared to the mutant. Moreover, the mutant 
structure shows higher atomic density distribution relative 
to the wild structure. Also, the L245P mutant complex 
occupies a larger phase space and exhibits a higher 
fluctuation compared to the wild-type complex. The cross-
correlation matrix and a graph of the correlated and anti-
correlated motions in the wild type and mutant system 
are shown in Figure 6B-6C, respectively. These results 
indicate that a specific residue is established with all the 
other residues during 130 ns simulation. Specifically, the 
single mutation of L245P mutant causes a change in the 
profile of the cumulative correlation motions localized 
along the entire bHLH-Zip domain. This effect indicates 
that a partial folding of the mutant protein region has 
mostly anti-correlated motion, which is primarily involved 
in interactions with other domains. 
Illustrated by the porcupine plots, alterations in 
the direction of residue domain for motion could provide 
information about the residue dynamics of the related 
regions in the protein during the simulation. Generally, 
the first three normal modes indicate the overall motion 
represented by the macromolecules during a simulation. 
We analyzed the motion modifications between two 
systems i.e., wild and L245P mutant along different modes 
1, 2 and 3 (Figure 7). The results show that the overall 
Figure 6: Dynamical effects of the p. L245P mutation on the PROM1 ‎protein. A.. PCA scatter plots along the pair of first two 
principal components, PC1 and PC2 for the wild-type and the L245P mutant showing differences between both types of eigenvectors. This 
represents optimal two-dimensional projections of the data over the 130 ns molecular dynamic trajectories. B. Cross correlation matrix 
C-alpha atomic graph and plot in during 130 ns simulation for the wild and C. the mutant systems. The range of motion is indicated by 
various colors in the panel. Red indicates positive correlation, whereas blue indicates anti-correlation. Totally, the L245P mutant effected 
a partial folding of the mutant protein region have the mostly anti-correlated motion; which is primarily involved in the interaction with 
other domains. These molecular changes were clearly depicted in the atomic density of distribution plot. There was a significant change in 
density distribution in native compared to the mutant. Moreover the mutant structure (L245P) shows highest atomic density distribution 
relative to the wild structure.
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motion between two systems, as shown by the graph, is 
wide-ranging and different. In comparison, most motion 
between the wild type and L245P mutant systems was 
caused by residues number 183-191 and 250-255 across 
mode 1, graphed in the Figure 7A. A higher mobility 
frequency was observed in the residues number located 
at 120-180 and 250-255 in mode 2. Residue behavior at 
these positions is emphasized at the partial opening of the 
mutant and complete closing of all parts of the wild type. 
This observation was also seen in the residues number 50-
100 and 230-255 of mode 3. Evidently, residues number 
70-77 and 183-191 also played significant roles in the 
secondary structure modifications of the mutant systems. 
These results are consistent with the RMSF plot, in which 
the mentioned regions are highly vibrant compared to the 
other locations. Most of the motions for the wild type were 
due to residues number 150-180 across all three modes 
as shown in Figure 7B. The wild type shows a twisting 
motion from C-terminal to N-terminal based on the 
direction of the residue movement in all parts of protein. 
Furthermore, the direction of the above residues number 
points toward the center of the active site spatially in 
the bHLH-Zip domain, thus creating a suitable location 
in the membrane to launch several signaling cascades. 
Table 3 highlights the list of residues that attributed to 
the majority of motions across different normal modes 
in wild and mutant types. As enumerated in Table 3, the 
residues with the highest motion include number 70-90 
and 220-250 especially at position 245th. These situations 
are more mobile than the wild type across three normal 
modes. These results are consistent to the Figure 4A, 
which showed higher motion in the α2 region i.e., bHLH-
Zip domain.
Dynamically, all these projections show that the 
mutant complexes have high values, signifying a large 
increase in the flexibility in comparison to the wild 
Figure 7: Mobility effects of the p. L245P ‎mutation on the PROM1 ‎protein. A. Residue based mobility plots of the wild and 
mutant showing mobility at different residues across different modes. B. Porcupine plots in the three different modes of the wild type 
(blue) PROM1 protein. This graph shows the number of residues 70-77 and 183-191 playing significant roles in the secondary structure 
modifications of the mutant form. C. Motion in the three different modes of the L245P mutant PROM1 protein. Arrows in blue, green, 
and red indicate motions along mode 1, 2, and 3 respectively. These figures clearly show that the L245P mutation affected the overall 
conformational fluctuation of the system. Our results indicate the most motions in mode 1 located in residues number 183-191 I. and 250-
255 (II) (mode 1), 120-180 (III) and 250-255 (IV) (mode 2), as well as 50-100 (V) and 230-255 (VI) (mode 3).
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complex during the collective motion of the PROM1 
protein; this pathogenic and deleterious mutation made 
the PROM1 protein less stable compared to the wild type 
protein complex (Figure 7B-7C).
The L245P mutant induces instability in free 
energy landscape
To assess the individual amino acid contribution 
to the total free energy profile in a simulation between 
the wild and L245P mutant, the interaction energy for 
the previously mentioned residue was carried out using 
GROMACS package by principle component analysis 
(PCA). As shown in Figure 8, energy distribution is a 
centralized form, indicating the overall conformational 
stability of the system. However, the highest mobility and 
fluctuation were observed in the L245P mutant, which 
was depicted as the higher FEL. The lowest energy for the 
wild type system was found to be 0.113 kcal/mol (Figure 
8A), while the mutant variant was 0.605 kcal/mol (Figure 
8B). These figures show that the L245P mutation affected 
the overall conformational stability of the system. These 
energy levels induced instability in the general structure 
of the protein. Thermodynamic profile analysis in Figure 
8 indicates that longer population of ‎conformations had 
higher energy in the L245P-mutant (0-14.5 kcal/mol) 
compared to native ‎type. ‎This observation is consistent 
with previous PCA scatter and the porcupine plot, further 
supporting that the L245P mutant decreases the stability.
DISCUSSION
In this genetic analysis study, we performed TES 
arrays to identify the genetic defect in a Chinese family 
with multi-cases of STGD4-like MD retinal degenerations 
(M107). Using this approach, we successfully identified 
a novel c.734T > C (p.L245P) PROM1 heterozygous 
mutation. Our findings highlighted that the variant in the 
PROM1 gene was likely a deleterious and disease-causing 
mutation in this M107 family, thereby expanding the 
PROM1 mutation spectrum for STGD4-like MD. Then, 
Figure 8: Free energy landscape (FEL). Projections of FEL of the wild A. and the L245P mutant PROM1 B. conformational 
space onto PC1 and PC2 produced from PCA. The dark blue indicates the lowest energy configuration and red shows the highest energy 
configuration. These energy levels induce the instability in the general structure of mutated protein. This observation is consistent with the 
PCA scatter and the porcupine plot.
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the protein structure-based virtual screening analysis was 
performed to identify the protein structure and function of 
c.734T > C (p.L245P) mutant. Furthermore, atomic level 
study was performed by molecular dynamic simulations 
to better understand the effects of the deleterious variant 
on p.L245P in active site domain of PROM1. The 
computational prediction methods’ results clearly showed 
that a novel PROM1 heterozygous mutation significantly 
affects the protein structure and function, including 
fluctuation, flexibility, atomic density distribution, and 
stability.
Despite extensive investigations on STGD4-like 
MD, the details of its etiology and pathogenesis remain 
unclear. Familial, identical, and adoption studies have 
consistently recommended that genetic variation is the 
most important general factor, which would be an indicator 
of its high heritability [2, 24-29]. Clinical variability exists 
in the STGD-like MD, even the same gene of different 
point mutations can cause variance phenotypes [30]; 
importantly, different genes caused the STGD-like MD, 
examples include families with ELOVL4 mutation, ABCA4 
mutation, and PROM1 mutation [4, 5, 9, 10, 12, 18-20, 
22]. In general, the STGD4-like MD is juvenile-onset MD 
that is generally related to an ELOVL4 mutation following 
PROM1. But, most STGD-like MD subjects maintained 
normal vision until the sixth decade of life. This gradually 
progressive disease is diagnosed with photophobia, 
paracentral scotoma, slow dark adaptation, and loss 
of color and central vision. Symptoms and prevalence 
of STGD-like MD are the same in altered individuals; 
members of the same family can show variations in the 
course of the illness [11]. Clinically, it is hard to predict 
or screen exactly when the disease will be evident and 
how fast it will develop, according to marked phenotype 
variability. It is well established that TES is a cost-
effective and an expedited approach to screen and identify 
pathogenic mutations responsible for inherited disorders 
on a large scale in comparison to other genetic methods 
[31, 32]. This is a predominantly accurate technique when 
the study conditions are particularly heterogeneous, as in 
a STGD-like MD [33]. By helping to advance imaging 
techniques, we have been able to further characterize this 
disease [34]. 
For the first time ever, this study characterized the 
novel pathogenic mutation in three-dimensional protein 
structure, analyzing this change at the structural level. Our 
findings show that c.734T > C (p.L245P) is functionally 
damaging and the disease-causing mutation in protein; 
therefore, we introduce it as a candidate for further 
clinical precision diagnosis and interpret that the same 
gene mutation leads to varying onset at different ages, a 
characteristic that is clinically useful for early prevention. 
It has been widely accepted that the computational 
and theoretical methods such as molecular dynamic 
simulation, PCA, FEL, and RINs analysis (with parameters 
of molecular dynamic to describe motion, stability and 
intercellular binding, respectively) can be used to detect 
and investigate the effects of lethal polymorphisms on the 
function and structure of protein [35-40]. Understanding 
protein conformational changes properly can elucidate 
the mechanisms underlying MD disease phenotypes for 
designing suitable drugs and medical managements. In 
this study, these methods clearly explained the impact 
of the mutation on the active site of the PROM1 protein, 
before undertaking further validation by experimental 
methods. Mutation of the residue alters the overall active 
site energy by ~ +6.25 kcal/mol and affects the landscape 
of the protein and atomic interaction of key residues. The 
different molecular dynamic parameters such as RMSD, 
RMSF, DSSP, and Rg index confirmed that the p.L245P 
pathogenic ‎mutation changes the molecular stability and 
flexibility as well as the amino acid interaction network 
and 3D conformational landscape. Interestingly, hydrogen 
bond interactions and van-der Waals forces of Pro245 with 
His242, Val73, Asn69, Leu248, Glu249, and Ile241 ‎in the 
α-helical structure of bHLH-Zip domain significantly 
increased to maintain a stable contact of the mutant form 
of PROM1, whereas total protein stability was reduced due 
to fluctuation in the hinge region of the mutated structure. 
The substitution of deleterious L245P mutation might 
change the electrostatic charge distribution in proteins and 
affect normal interactions. From this analysis, we suggest 
that the mutated PROM1 domain has drastically decreased 
functionality and stability capacity as a consequence of 
the partial unfolding of the α2/α3 helices in the bHLH-
Zip domain. This mutation led to a change of a neutral 
amino acid residue, Leu, to a nonpolar charged residue, 
Pro, located at the basic repeating unit of the bHLH-Zip. 
The Leu position in bHLH-Zip plays an essential role in 
transcriptional regulation of PROM1 [41]. It is likely that 
the substitution may impair protein stability and proper 
function, leading to the STGD4-like MD disorder [42]. 
The Pro mutation in the bHLH-Zip domain may destroy 
the PROM1 transportation [43], a phenomenon possible 
and consistent in our patient’s observation. Consequently, 
this instability and inflexibility affected the main function 
of PROM1 in the plasma membrane invaginations and 
disk malfunction, trapping it in the myoid region of 
the photoreceptors. Functionally, the PROM1 protein 
is necessary for disk formations in the photoreceptor 
cells. PROM1 has an influence on the formation and 
organization of disk within the photoreceptors. Mutations 
in PROM1 gene would trap PROM1 in the myoid region 
of the photoreceptors, preventing it from migrating to 
the site that formed disks. Accordingly, abnormalities in 
PROM1 positions in the photoreceptors cells will lead 
to disk malfunction. Previous studies have shown that 
different mutants undergo different misfolding pathways 
and exhibit different pathogenesis according to the 
different MD-related diseases [10, 12, 18-20]. In addition 
to an autosomal recessive PROM1 early-childhood-
onset retinopathy, an autosomal dominant later-onset 
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macular retinal phenotype has been documented in some 
individuals heterozygous for PROM1 mutations [18, 44], 
including in our study. 
To the best of our knowledge, this is first report 
that identified and characterized a novel c.734T > C 
(p.L245P) mutation of PROM1 with STGD4-like MD 
using the TES and multiple molecular dynamic analyses. 
The findings clearly confirmed that the variant in the 
PROM1 gene is most likely the deleterious and disease-
causing mutation in our studied family. While variants 
with incomplete segregation would be regarded as low 
to moderated penetrance effectors, complete segregation 
of a one novel variant (in PROM1 gene) demonstrates 
the variants are noteworthy candidates in case-control or 
population studies; however, it warrants more extensive 
studies of the PROM1, including in various ethnic groups. 
Altogether, this study provides compelling evidence 
that the PROM1 gene mutation should contribute to the 
progressive causativeness or susceptibility in patients 
with STGD4-like MD, as well as defines a new approach 
into the genetic characterization, precision diagnosis and 
prevention for STGD4-like MD disease.
MATERIALS AND METHODS
Ethical consideration, patient information, and 
clinical assessment
The study was approved by the Ethical committee of 
Southwest Medical University according to the Helsinki 
Declaration (1983 Revision) [45]. The cases were coded, 
and measurements were made in a blinded fashion by 
molecularist.
A four-generation, 18-related Chinese patients 
(M107) with familial STGD4-like MD was recruited. 
The genetic and full pedigree structures of the subjects 
are shown in Figure 1A. The patient proband claimed 
to have eye problems since the age of 42. All patients 
were diagnosed with STGD4-like MD by an experienced 
ophthalmologist; we also documented the patients’ 
inheritance patterns, ethnicity and summary information 
regarding the numbers of affected subject and members 
who were available for sampling. We obtained medical 
history and standard ophthalmologic examinations 
including best corrected visual acuity measurements, 
slit-lamp biomicroscopy, and color vision tests in all 
available family members. In addition, FP, FA (Spectralis; 
Heidelberg Engineering, Heidelberg, Germany), visual 
field tests (Carl Zeiss, Germany), and retinal structure 
were examined by OCT (Carl Zeiss, Germany). ERGs 
were performed using corneal “ERGjet” contact lens 
electrodes (RetiPort ERG System; Roland Consult, 
Wiesbaden, Germany) [45]. The ERGs protocol complied 
with the standards published by the International Society 
for Clinical Electrophysiology of Vision.
DNA sampling
Peripheral blood samples in the pedigree M107 
family and unrelated ethnically matched healthy control 
volunteers with no family history of this disorder were 
collected. gDNA was extracted from peripheral blood 
lymphocytes according to the standard phenol-chloroform 
method [45]. The DNA quality was measured by a 
NanoDrop-2000-spectrophotometer. High quality intact 
genomic DNA with optical density ratio of 260/280~ 1.8 
and 260/230 > 1.5 were used for further analysis.
Design of exome capture panel
Illumina paired-end libraries (Illumina, Inc., 
San Diego, CA) were generated according to the 
manufacturer’s sample preparation protocol for gDNA [46, 
47],. TES on an affected family member was randomly 
sheared by sonication into fragments of about 300-500 
bp and then hybridized to the precapture libraries, which 
were quantified (PicoGreen fluorescence assay kit; Life 
Technologies, Carlsbad, CA); their size distributions were 
determined by a commercial bioanalytical system (Agilent 
2100 BioAnalyzer; Agilent Technologies, Santa Clara, 
CA). For each capture reaction, fifty pre-captured libraries 
(60 ng/library) were pooled together. Hybridization and 
wash kits (Agilent Technologies, Santa Clara, CA) were 
used for the washing and recovery of captured DNA 
following the standard manufacturer’s protocol. Captured 
libraries were quantified and sequenced (Illumina HiSeq 
2000; Illumina, Inc.) as 100-150 bp paired-end reads, 
following the manufacturer’s protocols whitch performed 
at the BCM-FGI core. More than 99% of the targeted 
coding exons were covered by at least 10 folds non-
redundant sequencing reads.
Variant filtering and homozygosity mapping
After passed quality control (QC) of the illumina 
reads ( > 70-80% Q30 data, < 0.5% error rate), Burrows-
Wheeler Aligner (BWA) V7.10 was used to access 
sequence reads to the human reference genome from 
available public online UCSC database (http://genome.
ucsc.edu/), version hg19 (build 37.1). Next, recalibration 
and local realignment were analyzed using the Genome 
Analysis Toolkit (GATK version 1.0.5974), and the refined 
sequencing results were subjected to variant calling using 
a toolkit (Atlas2). Variant annotation was performed 
by applying ANNOVAR. Sequencing depth > 4, the 
estimated copy number ≤ 2, SNP quality > 20 (score 20 
represents 99% accuracy of a base call) and the distance 
between two SNPs > 5 were considered the filtration 
criteria for candidate SNPs [48]. We first searched for 
known pathogenic mutations in STGD candidate genes 
and then variants with a MAF (Minor allele frequency) 
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of less than 5% allele frequency in databases of 1000 
Genomes Project (1000genomes release_20100804, 
http://www.1000genomes.org/). In total, the average of 
4000 SNPs and INDELs were found after applying these 
filters. Subsequently, the phenotype of all cases was 
considered to be similar. At first approach, our focus was 
on identifying common variants among affected subjects 
between families, but we also identified any shared variant 
related to STGD. Consequently, we searched for variants 
within STGD-related genes in proband (depicted in Figure 
1A with pedigree II:2) separately. The selected variants 
were further analyzed in respect to whether they are 
homozygous or heterozygous.
Mutant confirmation and segregation analysis
For mutant confirmation and segregation analysis, 
we designed locus-specific primers using the online 
Primer3 program (http://primer3.ut.ee/) for polymerase 
chain reaction (PCR) amplification of prioritized variants 
and direct sequencing, upon the gDNAs of family 
members. Then, the PCR products were validated and 
confirmed by Sanger sequencing methods on an ABI 
3500DX sequencer (Applied Biosystems Inc., Foster City, 
CA, USA) with the specific primers. Then, all results were 
analyzed by Sequencing Analysis v.5.2 software (Applied 
Biosystems). All analyses were performed with two 
replicates per sample; a non-reverse transcription control 
and non-template control for each test. The specific primer 
sequences of PROM1 gene variant for Sanger sequencing 
are listed in Supplementary Table 2.
Mutation analysis in silico
The damaging effects of heterozygous mutations 
(c.734T > C mutation)‎ on PROM1 protein functions 
were evaluated in silico using online web server 
Mutation Taster (http://www. mutationtaster.org/) [49], 
Polymorphism Phenotyping version 2 (PolyPhen-2, 
http://genetics.bwh.harvard.edu/pph2/) [50], SIFT (http://
sift.jcvi.org/) [51], Have Your Protein Explained (HOPE) 
[52], and PANTHER (http://www.pantherdb.org/tools/
csnpScoreForm.jsp) programs [53]. Functional impact 
of the mutation was documented as ‘‘tolerated’’ or 
‘‘damaging’’ for SIFT and as ‘‘polymorphism’’ or ‘‘disease 
causing’’ for Mutation Taster. PolyPhen-2 classifies 
predicted effects of amino acid substitutions, marking 
the function of human proteins as ‘‘benign’’, ‘‘possibly 
damaging’’, ‘‘probably damaging’’, or ‘‘unknown’’. To 
predict stability changes upon mutation from the protein 
sequence or structure, I-Mutant3.0 was used based on the 
stability predictors (DDG < 0: decrease stability, DDG > 
0: increase stability) [54]. Pairwise alignment between 
template and target were performed by EBI/EMBL. Also, 
NCBI online data bases (http://www.ncbi.nlm.nih.gov/) 
were used to analyze the PROM1 conservation in deferent 
organism gene by inputting the data into the HomoloGene 
software of NCBI “Show Multiple Alignment” and 
Jalview software [55].
Homological based modeling
The sequence of human PROM1 was downloaded 
from the universal protein resource (http://www.uniprot.
org) (Entry: O43490). The template for sequence 
alignment was identified by searching human PROM1 
on PDB using the BLASTp program. The 3D structure of 
PROM1 (XKD) was created using MODELLER version 
9.17 [56], then the model was viewed using PyMol 
software [57]. The initial coordinates of PROM1, which 
were used in our molecular simulations, were based on 
crystal structure of the template protein (PDB Entry: 
4wid). A mutation of Leu to Pro at position 245th was 
generated in silico from the wild-type crystal structure 
using Pymol software [58]. The general streochemical 
quality of the final modeled protein structure was 
evaluated using PROCHECK [59], ProSA-web (protein 
structure Analysis) [60], RAMPAGE, and QMEAN 
analysis [61]. 
Molecular dynamic simulation
Molecular dynamics (MD) simulations investigate 
the motions and fluctuations of a system containing 
discrete particles under the impact of internal and external 
forces. The role of this application base on this method 
is broad, ranging from atoms to a molecule. The initial 
3D structure made from modeler was optimized using 
molecular dynamic simulation. The 130 ns simulations 
of p.L245P on the active functional extracellular domain 
of PROM1 (position 179-433, Supplementary Figure 3) 
were performed using the GROMCS molecular dynamics 
package version 5.1.3, which, on the Centos linux system, 
implements GROMOS96 package version 43a1 force 
field. pdb2gmx tools from GROMACS software package 
was applied to generate the topology file. The 3D human 
PROM1 was surrounded by a cubic periodic box of the 
simple point charge model of water molecules with a 
margin of 1.0 Å along each dimension. [62]. In detail, 
the number of water molecules in the cubic cage was 
approximately 120,000. Also, the molecular dynamical 
systematic simulations charges were neutralized by 
using sufficient Na+ and Cl- ions. All covalent bonds to 
hydrogen atoms were constrained using the SHAKE 
algorithm. Electrostatic interactions were calculated 
using the particle-Mesh Ewald algorithm [63] with a 
cutoff of 10 Å for Lenard-Jones interactions. Periodic 
boundary conditions were applied to avoid edge effects. 
Prior to molecular dynamic production, 50,000 steps of 
steepest-descent minimization were used to the solvent. 
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After energy minimization, the system was equilibrated 
with NVT (isochoric-isothermal) and NPT (isothermal-
isobaric) ensembles under the condition of position 
restraint for heavy atoms, with 100 ps with gradual 
heating from 300 K [64]. In addition, stable salt bridges 
were extracted based on a distance cut-off value of 0.4 
nm. The atomic coordinates of each model were saved 
every 1-ps for the analysis. The temperature and pressure 
coupling was applied using the modified Berendsen 
thermostat algorithm [65] at 300 K and Parrinello-Rahman 
algorithm [66] at 1 atmosphere with a link constant of 0.1 
ps and time duration of 100 ps. The comparative analyses 
were saved every 1 ps time interval for further analyses, 
including RMSF for all human PROM1 structures. 
RMSD, secondary structure modifications, Rg, hydrogen 
bond occupancy, secondary structure analysis, PCA, 
and clustering analysis were performed for the wild-
type and mutated form [67]. Additionally, the structural 
changes were visualized using VMD version 1.9.2 and 
Pymol software. The plots were conducted using xmgrace 
tool and secondary structure analysis, by DSSP of the 
GROMACS packages, respectively. Furthermore, a 130 ns 
molecular modeling trajectory of the system was obtained 
under constant pressure at 300 K using the GROMACS 
software package.
Residue interaction networks of the wild- and 
mutant-type
To analyze the mutatant residue on protein sequence, 
we used the open source software platform, Cytoscape 
v3.3.0 [35]. Cytoscape allows us to map the various 
‎interactions of wild- and mutant-type residue sources 
data in RIN models. In this regard, the average structure 
derived from the 130 ns trajectory of each system, wild 
type and L245P mutant was used to construct the RINs 
in 2D graphs using RING 2.0 web server [68]. This is a 
new version of the RING software for the identification 
of covalent and non-covalent bonds in protein structure. 
After determining the interaction between amino acids, 
RING used several tools to define non-covalent interaction 
between the amino acids, including hydrogen bonds, salt 
bridges, and interaction in closest atom. We mapped 
the information about the protein mutation and natural 
variation of a PROM1 protein onto all the corresponding 
nodes in the pathway. All the processed residues 
(functional extracellular domain of PROM1 in position 
179-433) were separately imported into Cytoscape 3.3.0 to 
reconstruct amino acidic networks using RINalyzer plug-
in software [36]. Therefore, the Cytoscape archive files 
were constructed by ‎submitting the crystal structure of 
both the wild type and the mutant protein to RING server 
[37].
Analysis of molecular dynamic trajectory
The trajectory files were analyzed using gmx rms, 
gmx rmsf, and gmx gyrate GROMACS utilities to obtain 
the RMSD, RMSF, and Rg. The numbers of distinct 
intermolecular hydrogen bonds formed between all 
residues during the simulation were calculated using gmx 
hbond utility. Secondary structure analyses using DSSP 
module were performed for both the wild type and L245P 
mutant over the whole simulation period. 
Circular dichroism spectroscopy analysis
The secondary structure of the wild-type and 
p.L245P mutant system were determined by CD 
spectroscopy during 130 ns modeling using DichroCalc 
server [69]. CD spectroscopy is a well-established 
technique for measuring the secondary structure, 
dynamics, and folding pathways of proteins ‎in the “far-
UV” spectral region (190-250 nm); where alpha-helix, 
beta-sheet, and random coil structures each give rise to a 
characteristic shape and magnitude of CD spectrum [70]. 
Principal component analysis (PCA)
PCA is a method that reduces the complexity of the 
data and extracts the concerted motion that are essentially 
correlated and presumably meaningful for biological 
functions during simulations. PCA was performed to 
determine the correlated motions of the residues to a 
set of linearly uncorrelated variables named principal 
components that are significant for the biological function 
of the protein during the course of simulation [38]. In PCA 
analysis, a variance/covariance matrix was constructed 
from the trajectories after the removal of the rotational and 
translational movements. PCA is a widely used protocol 
to simplify eigenvectors and eigenvalues of bio-molecules 
from the molecular modeling trajectories by relating it to 
the dimensional reduction method. GROMACS utility 
tools were used to perform PCA, with using normal mode 
wizard of VMD. PCA scatter plots were then created by 
the xmgrace program.
Free energy landscape (FEL)
FEL promotes the dynamic energy distribution 
and structure-function correlation of mutational residues 
variable in the protein system, which helps to visualize the 
stability of wild and mutant conformations for a protein 
[39]. The free energy minima regularly characterizes 
the conformational group in the stable states. The free 
energy barriers represented by the transient states of free 
energy values of backbone atoms in different systems, 
according the Gibb’s free energy method [40]. In this 
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study, we compared FEL values to identify the dominant 
conformational states, function of the enthalpy, and 
entropy of protein in wild and mutant conformations of 
PROM1 protein by using GROMACS package software 
based on the PCA data. 
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